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Abstract:
Astrocytes are one of the most abundant cell types in the central nervous system (CNS),
playing an important role in regulating the homeostasis of the CNS through various functions. A
number of functions of astrocytes are regulated by the canonical Wnt/β-catenin pathway, a prosurvival pathway that regulates transcription of thousands of genes via β-catenin as the central
mediator. While the pathway is known to be expressed in several human sources of astrocytes,
such as primary fetal astrocytes and gliomas, the pathway is not yet studied in human induced
pluripotent stem cell (hiPSC) induced astrocytes (iAs), which are proliferative and provide a
more biologically relevant source of astrocytes compared to other sources.
Therefore, in this study we seek to determine whether the Wnt/β-catenin pathway is
robustly expressed in iAs. Using reverse transcription-qPCR (RT-qPCR), we detected robust
mRNA expression of T-cell/lymphoid enhancer factors (TCFs/LEFs), transcriptional factors that
participate in the Wnt/β-catenin pathway, namely TCF1, TCF3, TCF4 and LEF1. Furthermore,
western blot demonstrated visible detection of active β-catenin (ABC) in iAs. Lastly, we
demonstrated that when Topflash plasmid, a specific reporter of the Wnt/β-catenin pathway, is
transduced and integrated into iAs via lentiviral approach, the activity of the reporter was quite

well detected and further, treatment of the cells with CHIR99021, an agonist of the pathway,
resulted in significantly higher reporter activity. Taken together, these results clearly demonstrate
that iAs robustly possess the Wnt/β-catenin pathway.

Introduction:
Astrocytes are one of the most abundant cell types in the central nervous system (CNS),
playing an important role in regulating the environment, such as by participating in glutamate
uptake, immunoinflammatory response of the CNS, and supporting the blood brain barrier
(Sofroniew & Vinters, 2010). Sourcing a consistent supply of primary astrocytes for in vitro
experiments is vital to understanding their role in CNS health and biology. In the past, astrocytes
were mainly sourced from adult deceased brains, gliomas (U87MG, U138MG), aborted fetal
tissues, and mice/rat brains. However, such sources can be difficult to access and may not be
biologically relevant to the studies at hand. For instance, astrocytes sourced from deceased adult
and fetal tissues are difficult to access due to legal implications and scarcity. Furthermore,
astrocytes sourced from fetal tissues may not be completely biologically relevant as they have
been shown to transcriptionally express certain genes less than adult astrocytes (Zhang, 2016).
Mice primary astrocytes, while they are easier to access, show several transcriptional and
phenotypic differences compared to adult primary astrocytes (Zhang, 2016). Similarly, astrocytes
sourced from gliomas, while being readily proliferative when provided proper growth conditions,
may not be biologically relevant to certain studies due to their oncogenic nature.
In the recent past, hiPSCs (human induced pluripotent stem cells) were successfully
demonstrated to differentiate into induced astrocytes (iAs) via neural progenitor cells (NPCs)
when provided astrocyte growth factors, media, and sufficient time (Tcw, 2017). iAs have

become an important tool in studying astrocyte biology and function because they are consistent,
easily accessible and cost effective compared to fetal astrocytes. Furthermore, iAs are much
more biologically relevant than astrocytes derived from gliomas or mice CNS tissue (Tcw,
2017). Due to their proliferative manner and biological relevance to many studies, iAs are
increasingly becoming an important tool in the study of neural disorders.
The canonical Wnt/β-catenin pathway is a pro-survival biological pathway that is
robustly expressed in human astrocytes such as gliomas and fetal astrocytes. When extracellular
Wnt protein binds to LRP6 and frizzled receptors, it binds to and inactivates a protein complex
composed of GSK3 (Glycogen synthase kinase 3), Axin 2, APC (Adenomatous Polyposis Coli),
and CK1 (Casein kinase 1). This protein complex would normally phosphorylate/in-activate βcatenin, which signals its breakdown by proteasomes. Therefore, when Wnt is present, β-catenin
is not phosphorylated and active/non-phosphorylated β-catenin (ABC) builds up within the
cytoplasm, allowing the protein to enter the nucleus. β-catenin is known to activate Tcell/lymphoid enhancer factors (TCFs/LEFs), which promote the transcription of hundreds of
genes (MacDonald, et al. 2010). Essentially, when Wnt is present, transcription of TCF/LEF
promoted genes is upregulated (Image 1).

Image 1:

(a) When Wnt is not present, β-catenin is broken down, and TCF/LEF promoted transcription does not occur. (b)
When Wnt is present, active β-catenin builds up, and TCF/LEF promoted transcription occurs more often.

The pathway has been found to regulate many important astrocyte functions. For
instance, upregulation of β-catenin positively regulates glutamate uptake by inducing
transcription of glutamine synthetase and glutamate transporter-1 in the prefrontal cortex of
mice, a function essential to avoiding abnormal excitatory neurotransmission (Lutgen et al.
2016). Similarly, the pathway has been found to regulate immunoinflammatory response in the
CNS, which is largely controlled by astrocytes. For instance, upregulation of TCF/LEF
transcription factors positively regulates the transcription of Interleukin-6 and Interleukin-8, two
small cytokines/chemokine proteins that encourage immunoinflammatory response. Meanwhile
upregulation of β-catenin has been found to have the opposite effect (Robinson et al. 2020). The
Wnt/β-catenin also plays a role in transcriptional regulation of HIV in primary fetal astrocytes
and astrocytomas (Narasipura et al. 2012; Henderson et al. 2012).

The Wnt/β-catenin pathway is not yet formally characterized in iAs, which are
increasingly becoming an important source for in vitro experiments. Hence, in this study we
questioned whether the Wnt/β-catenin pathway is robustly expressed in iAs. Such information
provides insight into the applicability of iAs in studies concerning the Wnt/β-catenin pathway.

Methodology:
Cell Culture: iAs were differentiated from hiPSCs via neural progenitor cells (NPCs)
using a conventional and well established protocol (Tcw, 2017). hIPSCs were sourced from
RUCDR biologics. Cells were induced into NPCs in a monolayer cell culture using a
conventional neural induction protocol (StemCell Technologies). Afterward, NPCs were
differentiated to iAs with complete astrocyte medium (CAM), which contains astrocyte medium
(AM; ScienCell) supplemented with 2% by volume fetal bovine serum (FBS; ScienCell), 1% by
volume astrocyte growth supplement (AGS; ScienCell), and 1% by volume penicillinstreptomycin (AGS; ScienCell) in a 5% CO2 humidified atmosphere at 37°C. The iAs were
propagated over 10 to 12 weeks with every 2-3 days half media changes and weekly cell splitting
using accutase to ensure cell density did not exceed 15000 cells per cm2. Differentiated iAs were
propagated on coated plates or flasks and in the presence of CAM in a 5% CO2 humidified
atmosphere at 37°C and subjected to experimentations.
Reverse Transcription Quantitative Real Time PCR: The mRNA transcription levels
of TCF1, TCF3, TCF4, LEF1, GAPDH, EAAT1, EAAT2, EAAT3, GS (Glutamine Synthetase),
and APOE were quantified in the iA sample. Total cellular RNA was isolated using the RNeasy
mini kit (Qiagen, Hilden, Germany). RNA was digested with DNaseI (Sigma-Aldrich, St. Louis,
MO) for 15 min at RT and DNaseI was inactivated at 70 °C for 15 min. cDNA was synthesized

using qScript cDNA supermix (Quanta Biosciences, Beverly, MA). Real-time PCR was
performed using PowerUp SYBR green master mix (Thermo Fisher) in a fast real-time PCR
system (Applied Biosystems, Waltham, MA) using SDS V2.4 software. Reaction conditions
were 50 °C for 2 minutes for UDG (uracil-DNA glycosylase) activation and 95 °C for 2 minutes
for Dual-Lock DNA polymerase activation; followed by 40 cycles of denaturation at 95 °C for
15 seconds and annealing and extension at 60 °C for 60 sec. Melting curve analysis was
performed to ensure that only a single gene was being amplified. Primers sequences used are:
TCF1-F-5’-AGGCCAAGAAGCCAACCATCAAGA-3 and TCF1-R-5’ACTCTGCAATGACCTTGGCTCTCA-3’; TCF3-F-5’TGCAGTGAGCGTGAAATCACCAGT-3’ and TCF3-R-5’AATGGCTGCACTTTCCTTCAGGGT-3’; TCF4-F-5’TCGGCAGAGAGGGATTTAGCTGATGT-3’ and TCF4-R-5’CTTTCCCGGGATTTGTCTCGGAAACT-3’; LEF1-F-5’AAGCATCCAGATGGAGGCCTCTACAA-3’ and
LEF1-R-5’-TGATGTTCTCGGGATGGGTGGAGAAA-3’;
β-catenin-F-5’-TCTTGCCCTTTGTCCCGCAAATCA-3’ and
β-catenin-R-5’-TCCACAAATTGCTGTGTCCCA-3’;
GFAP-F-5’- CTGGAGAGGAAGATTGAGTCGC-3’ and GFAP-R-5’ACGTCAAGCTCCACATGGACCT-3’;
ApoE-F-5’- GGGTCGCTTTTGGGATTACCTG-3’ and ApoE-R-5’CAACTCCTTCATGGTCTCGTCC-3’;
EAAT1-F-5’- GGTTGCTGCAAGCACTCATCAC-3’ and EAAT1-R-5’CACGCCATTGTTCTCTTCCAGG-3’;

EAAT2-F-5’-TGCCAACAGAGGACATCAGCCT-3’ and EAAT2-R-5’CAGCTCAGACTTGGAGAGGTGA-3’;
EAAT3-F-5’- CGAAAGAACCCTTTCCGATTTGC-3’ and EAAT3-R-5’GAAGGTGACAGGCAGTGTTGCT-3’;
GS-F-5’- CTGCCATACCAACTTCAGCACC-3’ and GS-R-5’ATAGGCACGGATGTGGTACTGG-3’;
GAPDH-F-5’-TGACTTCAACAGCGACACCCACT-3’ and GAPDH-R-5’ACCACCCTGTTGCTGTAGCCAAAT-3’.
Amplification plots of the Cts of each of the genes were recorded over 40 cycles. Fold
change in mRNA expression was calculated using 2-ΔΔCt with GAPDH as the internal control gene
and EAAT1 as the calibrator (Livak and Schmittgen, 2001). Ct thresholds were determined by
the software at the point when linear growth in the amount of PCR product begins to level off.
Western Blot for β-Catenin and GAPDH: For western blot, cells were lysed with RIPA
buffer to extract cellular proteins and the total protein content was measured by BCA assay (BioRad, Des Plaines, IL). 10 µg of total cell lysate was separated by 10% SDS-PAGE, transferred
onto a nitrocellulose membrane, blocked with superblock (ThermoFisher) containing 1.5%
Tween 20 (T20) for 1 hour, and then cut into two pieces, one for active β-catenin and the other
for GAPDH. Each membrane was than incubated with primary antibody for overnight at 4°C for
β-catenin (1:5,000; β-catenin; Rabbit; Sigma, #C2206) or Glyceraldehyde 3-phosphate
dehydrogenase (1:50,000; GAPDH, Rabbit, Sigma, #G9545) overnight at 4°C in superblock1.2% T20. Membranes were washed extensively in TBS-T20 and incubated with a secondary
antibody conjugated to horseradish peroxidase (HRP) in superblock-1.2% T20 for 60 min at RT.

Membranes were again washed extensively in TBS-T20 and scanned using a medical film
processor, namely Konica Corporation, SRX-101 (year 1997).
TOPflash Reporter Assay: Half of the iAs were split and transduced with lentiviral
particle containing 7TFP (Addgene #24308) as the transfer plasmid. Lentiviral particles were
produced in HEK293 cells using three plasmids, pMD2.G (#12259), psPAX2 (#12260), and
7TFP as per established protocol. Expression vector 7FTP harbors firefly luciferase gene
downstream of 7 x TCF promoter areas. A portion of the TOPflash transduced iA samples were
then treated with CHIR99021, an inhibitor of GSK3, which subsequently promotes saturation of
β-catenin in the cytoplasm. CHIR99021 was prepared in a DMSO solution at 5mM, and then 0.5
µL of the CHIR99021 solution was added to 1mL of medium in each well, diluting the
concentration to 2.5 µM. In two iA samples, only 0.5 µL of DMSO was added as the negative
control. Two other iA samples were not treated with either DMSO nor CHIR99021, serving as
the control. After a two day incubation of TopFlash transduced cells with CHIR99021, each cell
sample was lysed using passive lysis buffer (PLB) and centrifuged at high speed to remove debri.
The concentration of protein in the sample was measured using bicinchoninic acid (BCA) assay.
After which, oxyluciferin, the substrate of the firefly luciferase enzyme, was added to 10 µL of
the lysed sample. The emitted light was recorded using a luminometer in RLU/sec and
normalized to the concentration of protein in the samples.

Results:
Figure 1:

a)

b)
Figure 1: RT-qPCR using was done to measure the mRNA transcriptional level of GFAP, APOE, EAAT3, EAAT2,
EAAT1, and GS in 40 day old iAs. (a) logarithmic amplification plot of the ΔRn recorded at each of the first 40
cycles. ΔRn is the normalized value of total light emitted by SYBR green that is bound to the PCR product. This
value is proportional to the amount of PCR product present at the end of each cycle. The Ct threshold value was
found to be 0.104 ΔRn. (b) fold change in the transcriptional level of various genes that are specifically expressed
within astrocytes. Values are normalized to GAPDH and compared to GFAP. The Ct value of GFAP was used to
calibrate because it was one of the lowest reported values in the transcription of various genes.

According to the amplification plot, we see that Glutamine Synthase (GS), Excitatory amino acid
transporter 3 (EAAT3), EAAT2, EAAT1, Apolipoprotein E (APOE), and GFAP were all

transcriptionally expressed because they reached the Ct threshold within 35 cycles. According to
the fold change plot, we see that the APOE, EAAT3, and EAAT2 were expressed more than the
other genes. GS was excluded from this fold change plot because the fold change was found to
be around 23,000, and including such a value would make the other bars too small to visualize in
a standard linear scale. Ultimately, this allows us to confirm that our iAs well expressed the
astrocyte gene markers GS, EAAT3, EAAT2, EAAT1, APOE, and GFAP.
Figure 2:

a)

b)

Figure 2: RT-qPCR was done to measure the mRNA transcriptional level of LEF1, TCF1, TCF3, and TCF4 in 40
day old iAs. (a) logarithmic amplification plot of the ΔRn recorded at each of the first 40 cycles. ΔRn is the
normalized value of total light emitted by SYBR green that is binded to the PCR product. This value is proportional
to the amount of PCR product present at the end of each cycle. The Ct threshold value was found to be 0.104 ΔRn.
(b) fold change in the transcriptional level of variousTCF/LEF genes normalized to GAPDH and compared to
GFAP. The Ct value of GFAP was used to calibrate because it was one of the lowest reported values in the
transcription of various genes.

According to the amplification plot, we see that LEF1, TCF1, TCF3, and TCF4 were all
transcriptionally expressed as they reached the Ct threshold within 35 cycles. This allows us to
confirm that our iAs well transcribed TCFs and LEFs. According to the fold change plot, we see
that the TCFs were expressed more than LEF1.
Figure 3:

Figure 3: Western blot was done to determine phenotypic expression in two samples of iAs treated with and without
CHIR99021 as well in iAs with and without TOPflash transfection. One sample of iAs were 71 days old on the day
of lysing while the other were 137 days old on the day of lysing. (a) Western blot portraying the protein expression
of active β-catenin (ABC) in transfected and non-transfected iAs treated with varying conditions. (b) Western blot
portraying the expression of GAPDH in transfected and non-transfected iAs treated with varying conditions.

ABC was clearly expressed in CHIR99021 treated iAs that were not transfected with
TOPflash. Meanwhile, in other cell samples, ABC was not as well present, which can be
discerned from qualitative densitometry of the ABC bands. While the presence of CHIR99021
may have led to the increased presence of ABC in the non-transfected iAs, a more likely source
of the discrepancy is that more protein was collected from these samples, which can be discerned
from qualitative densitometry of the GAPDH bands; the GAPDH band for the non-transfected,
CHIR99021 treated cells was much larger. The fact that ABC was not as expressed in transfected
cells that were treated with CHIR99021 further supports that the discrepancy in the presence of
ABC is due to the amount of protein present at the start of the electrophoresis; from looking at
the GAPDH bands, we see that even transfected iA samples expressed lower amounts of
GAPDH, hinting a lower initial protein concentration. Ultimately, the western blot demonstrates
that ABC is present in the CHIR99021 transfected iAs, and would have likely been more present
in the untreated cells if more protein was collected for that sample.
Figure 4:

Figure 4: Luciferase assay was done on iAs transfected with TOPflash plasmids after 48 hours. At hour 24, one of
the iA samples was treated with CHIR99021, which was delivered in a DMSO solution, while another sample was
provided an equal volume of DMSO. The above demonstrates the luciferase activity in the transfected cell samples
treated with CHIR99021 and the transfected cell samples that were not treated (control). Luciferase activity has been
normalized to the mass of protein (ug) loaded onto the luminometer.

In Figure 1, we see that amongst TOPflash transduced cells, CHIR99021 treated cells, were
nearly 373 times as luminescent as untreated cells. While only one sample of iAs were
experimented with for each condition, the sheer difference in luminescence between the two
shows that CHIR99021 has a noteworthy positive effect on the production of luciferase in
TOPflash transduced iAs. The fact that DMSO was provided to the control group demonstrates
that the effect on luminescence in the CHIR99021 treated sample did not arise because of
DMSO. Ultimately, we can confirm that CHIR99021 upregulated the production of luciferase in
TOPflash transfected iAs.
Image 2:

Figure 5: 104 day old untreated and untransfected iAs. Phase contrast microscopy was used to take pictures of the
iAs. The top two pictures are x200 magnification while the bottom two pictures are x100 magnification.

According to Image 2, we see that the iAs convey stellate morphology, a general
signifying trait of astrocytes.

Discussion:
Our iAs were differentiated from hiPSCs (human induced pluripotent stem cells) via
NPCs using a well established protocol (Tcw, 2017). We can confirm that our hiPSCs were
successfully differentiated into astrocytes because the cells portrayed astrocyte gene markers and
stellate morphology. We detected the transcriptional expression of EAAT1, EAAT2, EAAT3,
GS and APOE in the cells after 60 days after reaching the iA stage as per the instructions of the
protocol, all of which take part in important astrocyte functions such as glutamate uptake and
maintenance of cholesterol levels in the CNS (Anlauf & Derouiche, 2013; Schmitt, et al. 1997).
While EAAT1 and GFAP expression was especially low, they were still present to an extent.
Interestingly, the data for GFAP contrasts with that of another study, where in GFAP
transcription level was found to be transcriptionally expressed nearly 50 times as much as APOE
(Tcw, 2020). Furthermore, prior studies have shown that EAAT1 and EAAT2 are more present
in astrocytes than EAAT3 (Schmitt, et al. 1997). Despite the discrepancies, our iAs still resemble
astrocytes in that they express astrocyte gene markers.
Results from qPCR and western blot allow us to confirm that the iAs phenotypically and
genotypically expressed important components of the canonical Wnt pathway. We detected the
transcriptional expression of TCF1, TCF3, TCF4, and LEF1 genes, the main transcription factors
involved in the canonical Wnt pathway, in the iAs 60 days after reaching the iA stage as per the
instructions of the protocol. Furthermore, analysis of the western blot results confirm the
presence of β-catenin, the main mediator protein in the pathway. In total, the major components
of the activated canonical Wnt pathway are present in the iAs.

The luciferase assay demonstrates the individual components of the Wnt/Beta catenin
pathway interact together as established. We find that luciferase is much more expressed in
TOPflash transfected iAs when CHIR99021 is present. While CHIR99021 may affect many
different biological pathways, it is mainly known as a molecular inhibitor of GSK3, a protein
that phosphorylates/inactivates β-catenin when part of a protein complex composed of GSK3,
Axin 2, APC (Adenomatous Polyposis Coli), and CK1 (Casein kinase 1) (Naujok, et al. 2014).
Essentially, CHIR99021 is known to activate the canonical Wnt pathway by upregulating the
presence of ABC in the cytoplasm and nucleus, thereby increasing activation of TCF/LEF
factors. The transfer plasmid of the TOPflash DNA contains the luciferase downstream of seven
TCF promoters. Therefore, when a robust Wnt/β-catenin pathway is present, the presence of
CHIR99021 should lead to more TCF activation and transcription of luciferase than a situation
without CHIR99021 (Image 3). This is what is observed in the TOPflash transfected iAs,
confirming the interactions between the phosphorylating GSK3 protein complex, β-catenin, and
TCF transcription factors that make up the canonical Wnt pathway. Because TOPflash
transfection does not affect the presence of β-catenin nor TCF factors, we can confirm that iAs
also robustly possess these protein interactions. Ultimately, we show that iAs differentiated from
hiPSCs possess a robust Wnt/β-catenin pathway.
Image 3:

CHIR99021 inhibits GSK3, which leads to decreased phosphorylation of β-catenin and increased presence of ABC.
As a result, TCF promoted genes are transcribed more.

Future Direction:
The discovery of protocols to differentiate iAs from hiPSCs provide a source of relatively
easy to access biologically relevant cells for in vitro experimentation concerning astrocytes.
Rather than having to experiment using fetal primary astrocytes or glioma derived cells, which
can be difficult to access and may not be completely biologically relevant, iAs provide an easier
to access platform. The determination of the presence of a robust Wnt/β-catenin pathway within
astrocytes allows for experimentation concerning how the pathway may regulate characteristics
of astrocytes in different situations. In the future, by employing genetic engineering tools such as
CRISPR/Cas9 and siRNA,we hope to dissect new insights into the functional aspects of the
Wnt/β-catenin pathway in iAs including but not limited to glutamate uptake, neuronal function,
neuro inflammation, and immunoinflammatory response to injury.
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